Sign In
Buy OGN
$13.40
+0.0200 (+0.149%)
At Close: Jun 03, 2026
Organon To Present at the 41st Annual J.P. Morgan Healthcare Conference
07:30am, Thursday, 15'th Dec 2022
JERSEY CITY, N.J.--( BUSINESS WIRE )--Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a firesi
Organon & Co. (OGN) Presents at Piper Sandler 34th Annual Healthcare Conference
02:26pm, Tuesday, 29'th Nov 2022
Organon & Co. (NYSE:OGN ) Piper Sandler 34th Annual Healthcare Conference November 29, 2022 9:00 AM ET Company Participants Kevin Ali - Chief Executive Officer Matt Walsh - Chief Financial Officer Con
Organon: Q3 Results Show Promising Acquisitions But Mixed Portfolio Sales
09:17am, Thursday, 24'th Nov 2022
Organon's third-quarter results show third consecutive quarter of growth, with steady growth across divisions. From inception they have undergone a string of acquisitions and licensing deals that may
Organon & Co. (OGN) Q3 2022 Earnings Call Transcript
12:17pm, Thursday, 03'rd Nov 2022
Organon & Co. (NYSE:OGN ) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Jennifer Halchak – Vice President, Investor Relations Kevin Ali – Chief Executive Office
Organon To Report Third Quarter Results and Host Conference Call on November 3, 2022
07:30am, Thursday, 20'th Oct 2022
JERSEY CITY, N.J.
Jim Cramer gives his take on Organon
10:29pm, Tuesday, 18'th Oct 2022
Cramer on Tuesday explained his thoughts on pharmaceutical firm Organon.
Analysts Think 9 Cheapest Of The Cheap Stocks Are Worth A Shot
08:00am, Tuesday, 04'th Oct 2022
Buying S&P 500 stocks on the cheap isn't a winning way to make money long term. But that doesn't stop some investors from trying anyway.
Drugmaker stocks lead sector with healthy dividends
03:50pm, Friday, 23'rd Sep 2022
CNBC's Bertha Coombs reports on health care stocks.
Health care stocks with dividend yields to weather through market turmoil
09:19am, Friday, 23'rd Sep 2022
The healthcare sector is an investor favorite in a defensive market. CNBC's Bertha Coombs joins 'Squawk Box' to break down some players with the best dividend yields.
Organon: What Is The Recipe?
06:18pm, Wednesday, 31'st Aug 2022
Organon has seen a real struggle in its first year on its own as a publicly listed business. Lack of growth was anticipated, yet the extent of margin pressure has been unexpected.
New Strong Sell Stocks for August 8th
08:17am, Monday, 08'th Aug 2022
COWN, AUD, and OGN have been added to the Zacks Rank #5 (Strong Sell) List on August 8, 2022.
Organon & Co. (OGN) CEO Kevin Ali on Q2 2022 Results - Earnings Call Transcript
01:04pm, Thursday, 04'th Aug 2022
Organon & Co. (NYSE:OGN ) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Jennifer Halchak - Vice President, Investor Relations Kevin Ali - Chief Executive Officer Matt
Organon To Report Second Quarter Results and Host Conference Call on August 4, 2022
07:30am, Thursday, 21'st Jul 2022
JERSEY CITY, N.J.--(BUSINESS WIRE)-- #organon--Organon will release its second quarter 2022 financial results on 8/4/22, prior to the company's webcast and call scheduled for 8:30 a.m. EDT.
Organon Vs. Viatris: Who Is The Clear Winner?
09:23pm, Sunday, 19'th Jun 2022
Organon's P/E ratio was 6.5 at the end of Q1 2022, significantly lower than the pharmaceutical industry average. Viatris' revenue was $4,191.7 million in the first quarter of 2022, down 5.4% from a ye
Organon: Maximum Optimism
01:04pm, Thursday, 28'th Apr 2022
Biosimilar sales were $118 million in Q4 2021, up 14.6% from Q4 2020. Organon's dividend yield is around 3.5%, which is one of the largest in the pharmaceutical industry.
